Hawley returns to UNeMed


Dr. Hawley

Dr. Hawley

OMAHA, Neb. (November 28, 2022)—Amanda Hawley, PhD, has returned to UNeMed, bringing with her six years of industry experience into her role as Senior Licensing Specialist.

“Recruiting Amanda back to the University is a huge win,” UNeMed President and CEO Michael Dixon said. “We have the advantage of her already proven experience in tech transfer, but now leveled up with an impressive track record in private industry.”

Dr. Hawley initially joined UNeMed as an intern in 2014, then was a Licensing Fellow in 2015, before accepting a position at LI-COR, an international biotech company in Lincoln that develops research devices and reagents for a broad range of applications.

While at LI-COR, Dr. Hawley most recently served as Contracts Manager after a role as Business Development and Intellectual Property Manager from May 2016 to February 2022.

In such roles, she developed various training programs and policies, negotiated an array license agreements and operation-support contracts, and managed the biotechnology division’s intellectual property portfolio of legacy and launched products.

“My time in industry enabled me to see behind the curtain on the process and potential criteria when commercializing new products,” Dr. Hawley said. “I am excited to be back on the UNeMed team as well as collaborating with the passionate inventors of UNMC and UNO. By applying my expanded skillset, my hope is to enhance the reach of university innovations and to implement alternative strategies for moving technologies forward.”

A native of Portland, Ore., Dr. Hawley is the daughter of Jay and Debbie Lakamp, and a 2004 graduate of Sunset High School. She went on to Western Oregon University in Monmouth for her biology degree in 2009. Dr. Hawley received her doctorate in cancer biology from UNMC in 2014.

Comments are closed.